Skip to content

Methadone in TKA for Post-op Pain and Opioid Reduction

Reduction of Post-op Pain and Opioid Consumption With the Addition of Methadone in Total Knee Arthroplasty: a Double-blind Randomized Control Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07226076
Enrollment
162
Registered
2025-11-10
Start date
2026-01-08
Completion date
2027-01-15
Last updated
2026-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain

Keywords

post-operative pain

Brief summary

This randomized, double-blind controlled trial investigates whether intraoperative IV methadone (0.15 mg/kg based on ideal body weight) reduces acute postoperative pain and opioid consumption in patients undergoing elective total knee arthroplasty under spinal anesthesia with mepivacaine.

Interventions

Patients will intraoperatively be administered methadone 0.15mg/kg IV, based on ideal body weight.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Inclusion * Ages 18-75 years of age * Undergoing elective primary total knee arthroplasty with mepivacaine in the spinal anesthesia Exclusion * Allergy to methadone or mepivacaine * Severe liver disease defined as Child's Pugh Class C * End stage renal disease requiring dialysis * Known diagnosis of prolonged QT syndrome * Currently pregnant * Unable to provide written, informed consent * Non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
Patient reported pain in the recovery unit after surgeryup to 24 hours after surgery endsPatient reported pain on a Visual Analog Scale (VAS) from 0-100mm at approximately 30-60 minutes after arriving to the recovery unit after surgery. A lower pain score means a better outcome.

Secondary

MeasureTime frameDescription
Opioid Consumption in the recovery unitPACU Arrival until PACU Discharge up to 30 daysOpioid consumption measured in oral morphine milligram equivalents (MMEs) while the patient is in the PACU (Post-Anesthesia Recovery Unit).
Time to first opioid rescue doseup to 24 hours after surgery endsMeasured from the PACU arrival time, to the time the first opioid rescue dose is given while in the PACU.
Pain scoresPACU, 24 hours, 48 hours, and 72 hours post-operatively.Visual Analog Score (VAS) 0-100mm reporting pain at rest, and with movement. A lower pain score means a better outcome.
Postoperative nausea and/or vomitingPACU through 72 hours post-operativelyIncidence of postoperative nausea and/or vomiting after surgery as reported by the patient.
Quality of Recoveryup to 24-hours post-operativelyChange in quality of recovery score from baseline to 24-hours post-operatively measured using the Quality of Recovery 15 Assessment (QoR-15). This assessment is scored 0-150, with a higher score indicating a better quality of recovery. Each of the 15 questions is on an 11-point numerical rating scale from 0-10, and the selections are added together to result in the total score.

Countries

United States

Contacts

CONTACTHaley Nitchie, MHA
nitchie@musc.edu843-792-1869
PRINCIPAL_INVESTIGATORWilliam Barrett, M.D.

Medical University of South Carolina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026